We present two cases of women who suffered from neurotrophic keratopathy (one of them had undergone penetrating keratoplasty) which had led to corneal thinning. Tachosil® was used as an adjuvant treatment after topical medication by itself failed in both cases. To our knowledge, there are no reported cases of the use of Tachosil® in corneal grafts.
CITATION STYLE
Rahhal-Ortuño, M., Fernández-Santodomingo, A., Molina-Pallete, R., Hurtado-Sarrió, M., & Cisneros-Lanuza, Á. (2019). Use of Tachosil® as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation. Indian Journal of Ophthalmology, 67(7), 1198–1200. https://doi.org/10.4103/ijo.IJO_1573_18
Mendeley helps you to discover research relevant for your work.